Trial Details
COMPLETEDBasic Information
| Clinical ID | c1406 |
|---|---|
| Identifier | NCT00801723 |
| Trial Title | (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Budesonide MMX 6 mg Tablet|DRUG: Placebo Tablet |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-12-08 |
|---|---|
| Primary Completion Date | 2025-05-11 |
| Completion Date | 2025-06-11 |